Production cluster
An industrial cyclotron and radiochemistry facilities for radiopharmaceuticals based on fluorine-18 and gallium-68. The plan covers supplies for AURUM’s diagnostic network and other clinics.
ODESA. UKRAINE. A NEW HORIZON IN MEDICINE.
Science thatadvances life.
A new-generation medical isotope cluster. From in-house isotope production to precision diagnostics.
Investment concept · Odesa, Ukraine. Project parameters
€80mplanned investment
8PET/CT scanners in the project
4,000+patients a year · planned capacity
300 kmtarget supply radius
Four disciplines. One shared ambition.
Isotopes. Diagnostics. Research. Digital health.
Diagnostic network
Eight PET/CT scanners with a planned capacity of more than 4,000 patients a year. The proposed clinical focus spans oncology, cardiology and neurology, with public programmes considered as a potential payment channel.
Research and education
A platform for applied research, professional training and academic collaboration. This work is intended to develop technology and expertise within the cluster.
Digital health
Planned capabilities include AI-assisted image analysis, a digital diagnostic archive and remote consultations. These tools are intended to support medical professionals and collaboration between them.
Closer to life.
Precision diagnostics, closer to home.
AURUM is conceived to improve access to molecular diagnostics in southern Ukraine. Bringing radiopharmaceutical production and diagnostics into one system is intended to reduce reliance on external supplies and unnecessary travel for patients.
For patients
Diagnostics closer to home and a coordinated examination pathway.
For healthcare systems
Regional capacity, specialist training and the potential to work with public healthcare programmes.
For investors
Participation in medical infrastructure with two planned revenue streams and a phased development approach.
Designed as a whole.
The proposed campus, spanning more than 1,000 m², brings together a cyclotron, radiochemical synthesis laboratory, PET/CT equipment and IT infrastructure. Radiation protection, quality assurance and the necessary authorisations are integral to the implementation plan.
1 000+ m²planned cluster floor area
On-site production
An internal production base is intended to reduce dependence on imported radiopharmaceuticals and improve supply planning.
Clinical infrastructure
A single campus is designed to connect technical capacity with patient pathways and specialist teams.
A connected system
Production, logistics, diagnostics and digital services are planned as interdependent processes.
Regional reach
Odesa is the starting point.
Planned development directions. This illustration does not represent an operating supply network.
300 kmtarget supply radius
Odesa
The first phase focuses on establishing the production and diagnostic cluster and beginning patient services.
Ukraine
The next direction is a supply network for other healthcare providers. The presentation sets out a target logistics radius of up to 300 km.
Moldova and Romania
Further expansion is envisaged through cross-border supplies and collaboration with medical networks, subject to the required authorisations and validation of the logistics model.
Capital that becomes infrastructure.
€80mplanned investment
Planned capital expenditure is allocated across production, diagnostic equipment and campus construction. Each forms a distinct part of one operating system.
35%/€28m
Cyclotron and radiochemistry
A particle accelerator and radiopharmaceutical synthesis laboratory.
45%/€36m
PET/CT and digital infrastructure
Eight scanners, IT systems and planned AI-assisted image analysis modules.
20%/€16m
Campus construction
A specialised facility exceeding 1,000 m², with the required engineering infrastructure.
Planned capital allocation from the investment presentation.
Two revenue streams B2C / B2G B2B Discuss participation
Two streams. One business model.
Diagnostic services
The model envisages payments from patients, insurers and, subject to eligibility, public healthcare programmes.
Radiopharmaceuticals
Supply to other clinics is the second planned revenue stream alongside AURUM’s own diagnostic services.
50%+
modelled margin target
The presentation sets out this target under assumptions relating to internal production and equipment utilisation. It is a modelled benchmark, not a verified operating result or a guarantee of investment returns.
Medicine. Management. Long-term thinking.
Olha Psarova
Project Lead
A PhD candidate in public administration with a focus on healthcare, holding a master’s degree in business analytics and project management. The presentation also states a medical education and more than 15 years of business experience.
LinkedInResearch and management experience
The AURUM concept draws on research, business analytics and experience engaging with academic and civil society institutions. These disciplines inform the approach to structuring and developing the project.
European context
The presentation identifies EU4Health, Europe’s Beating Cancer Plan and IAEA and WHO approaches as strategic reference points.
Ukrainian and regional context
The concept relates to Ukraine’s cancer control priorities through 2030 and the Odesa region’s development priorities through 2027, while considering public-private cooperation mechanisms. These are the project’s stated reference points, not confirmation of official endorsement, funding or authorisations.
Implementation plan
From concept to operation.
The dates below reproduce the plan in the original presentation. They are not a report of current progress; updated timing and stage status are to be confirmed in project discussions.
- April–June 2026
Preparation
Investment structuring, campus design, licensing procedures and supplier selection.
- July–December 2026
Infrastructure
Construction of specialised facilities, equipment procurement and radiopharmaceutical logistics planning.
- January–June 2027
Installation and readiness
Cyclotron and laboratory installation, staff training, commissioning and required authorisations.
- From July 2027
Launch and development
Planned start of diagnostic services and B2B supply, followed by digital service development and regional expansion.
The next conversation
The future needs your ambition.
For investors, medical operators and prospective partners. Contact the project lead to discuss the concept, potential participation and next steps.
Contact the project leadAURUM / INVESTOR PRESENTATION
See the complete picture.
The concept, CAPEX allocation, financial model and implementation plan in one document.
Download the brochurePDF · English edition. A translation of the original Ukrainian presentation, including its initial assumptions and implementation schedule.